Michael J Rozema

USPTO Granted Patents = 8 (Patent Applications = 12)

CIPO Patents = 1 (Patent Applications = 13)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 105(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

patents

1 out of 61

Reata Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2011-2022

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11512092 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2022-11-29),

2. 11198697 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2021-12-14),

3. 11186584 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2021-11-30),

4. 9464082 - Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2016-10-11),

5. 9260411 - Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile (2016-02-16),

6. 8691865 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers (2014-04-08),

7. 7960564 - Crystalline chemotherapeutic (2011-06-14),

8. 7947843 - Crystalline chemotherapeutic (2011-05-24),

Title: Unveiling the Innovative Mind of Inventor Michael J Rozema

Introduction:

Michael J Rozema, a prolific inventor hailing from Kenosha, WI (US), has made significant contributions to the field of pharmaceuticals with his groundbreaking patents and innovative processes.

Latest Patents:

Rozema's latest patents include processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof. These inventions are geared towards treating rheumatoid arthritis, spondyloarthritic conditions, and various types of axial spondyloarthritis, showcasing his commitment to advancing medical treatments.

Career Highlights:

With a total of 8 patents to his name, Rozema has established himself as a leading figure in the pharmaceutical industry. He has worked with renowned companies like AbbVie Inc. and Abbott Laboratories Corporation, demonstrating his versatility and expertise in the field.

Collaborations:

Throughout his career, Rozema has collaborated with esteemed professionals such as Thomas B Borchardt and Lakshmi Bhagavatula. These partnerships have not only enriched his inventions but have also led to the development of cutting-edge pharmaceutical products.

Conclusion:

Inventor Michael J Rozema's unwavering dedication to innovation and his commitment to improving healthcare through his patented processes exemplify the true spirit of creativity in the field of pharmaceuticals. His contributions continue to inspire and pave the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.